Park Ha Biological Technology Co. Business Summary

Park Ha Biological Technology Co., Ltd. (BYAH) is a China-based skincare developer and distributor specializing in affordable solutions for problematic skin under its proprietary "Park Ha" brand. The company generates revenue through a dual-segment business model consisting of direct Product Sales and Franchise Service fees. Its operations are centered on a multi-channel retail strategy that includes three directly operated flagship stores and a network of 39 franchisees across China as of April 2025. To drive customer retention and brand loyalty, the company integrates a "light beauty experience" after-sales service, providing complimentary skin treatments at its physical locations. In the highly fragmented Chinese skincare market, BYAH competes directly with domestic players like Boqii Holding (BQ) and Jowell Global (JWEL), as well as specialized retailers such as Fitell (FTEL) and Leslie's (LESL). Positioned as a niche, small-cap growth player, the company recently secured $2.45 million in follow-on funding in January 2026 to aggressively expand its self-operated retail footprint. Leadership is spearheaded by Founder, CEO, and Chairperson Xiaoqiu Zhang, who maintains a controlling 72% stake in the company and has been the primary architect of the brand since its 2016 inception. The executive team includes Chief Financial Officer Xiaoyan Zhu and Chief Technology Officer Xinyu Li, who also serves as the lead Product Manager for the company's anti-aging and sebum-repair formulations. The Board of Directors is bolstered by Independent Director Yanan Shan, a veteran accountant with over 18 years of experience who previously served as CFO for Wuxi Al-Top New Metal Material. Despite its small market capitalization, BYAH has attracted a diverse roster of institutional investors, including XTX Topco Ltd, Two Sigma Securities, and Geode Capital Management. As of February 2026, the company is undergoing a significant capital restructuring, including a 1-for-50 reverse stock split scheduled for February 20, 2026, to stabilize its listing on the Nasdaq Capital Market.